Several studies reported that high PD-L2 expression was associated with poor patient survival, including studies in esophageal cancer32, pancreatic ductal adenocarcinoma42 and colorectal cancer38,39, and high tumor PD-L2 expression was associated with a favorable survival outcome in melanoma40 and colorectal cancer41. This evidence concerns the gene PDCD1LG2 and neoplasm.